Pharmafile Logo
Pharmafocus logo
Advanced Search

conjugate

Showing 2 posts of 2 posts found.

Takeda buys license to ImmunoGen cancer tech

March 24, 2015
Research and Development, Sales and Marketing ADC, Immunogen, Takeda, antibody, conjugate, merger

Takeda has licensed the exclusive rights to use ImmunoGen’s popular antibody-drug conjugate (ADC) technology to develop new cancer drugs. The …

News

Lilly teams up with ImmunoGen on antibody-drug conjugates

December 21, 2011
ADC, Cancer, Immunogen, T-DM1, conjugate, lilly, oncology

ImmunoGen has signed a new collaboration with Eli Lilly to develop antibody-drug conjugate for cancer treatments.Lilly will pay an upfront …

News
The Gateway to Local Adoption Series

Latest content

NanoSomiX and Beckman Coulter Diagnostics collaborate on blood tests for neurodegenerative diseases

July 30, 2026

EMA selects TrialAssure anonymisation platform for clinical trial documents

July 30, 2026

Researchers develop new antifungal compounds with improved safety profile

July 29, 2026

Lonza and Engitix partner to develop next-generation antibody-drug conjugates

July 28, 2026

Simris Group appoints Tiffany J Vora as Strategic Advisor

July 28, 2026